Palla Pharma Ltd
ASX:PAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Palla Pharma Ltd
ASX:PAL
|
AU |
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
A
|
Aiforia Technologies Oyj
OMXH:AIFORIA
|
FI |
|
E
|
Eik fasteignafelag hf
ICEX:EIK
|
IS |
|
Yasuda Logistics Corp
TSE:9324
|
JP |
|
Cannabix Technologies Inc
OTC:BLOZF
|
CA |
|
C
|
CleanCore Solutions Inc
AMEX:ZONE
|
US |
|
Waskita Karya (Persero) Tbk PT
IDX:WSKT
|
ID |
|
Audax Renovables SA
MAD:ADX
|
ES |
Palla Pharma Ltd
Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.
Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.
